Clin Osteol 2021; 26(1): 54-58

Osteoporosis associated with pregnancy: a case reportCase reports

Lokočová Eva; Horák Pavel
III. interní klinika - nefrologická, revmatologická a endokrinologická a LF UP a FN Olomouc

Osteoporosis associated with pregnancy and lactation is rare clinical condition resulting in acute back or hip pain in the event of an osteoporotic fracture. The etiology and pathogenesis of osteoporosis in pregnancy is not clear, the influence of abnormal hormonal effects on calcium metabolism and genetic predisposition is assumed, and pre-existing osteopathy is also a question. A detailed examination to assess secondary etiology is always necessary. The treatment of osteoporosis associated with pregnancy and lactation is based on adequate calcium and vitamin D substitution. Indications for therapy of osteoporosis are assessed individually, taking into account fractures or decreased BMD, an important indicator is BMD after lactation.

Keywords: densitometry; fractures; lactation; osteoporosis; pregnancy

Received: March 24, 2021; Accepted: April 12, 2021; Published: June 11, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lokočová E, Horák P. Osteoporosis associated with pregnancy: a case report. Clinical Osteology. 2021;26(1):54-58.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kim TH, Lee HH, Jeon DS et al. Compression fracture in postpartum osteoporosis. J Bone Metab 2013; 20(2): 115-118. Dostupné z DOI: <http://doi10.11005/jbm.2013.20.2.115>. Go to original source...
    2. Peris P, Guanabens N, Monegal A et al. Pregnancy associated osteoporosis: the familiar effect. Clin Exp Rheumatol 2002; 20(5): 697-700.
    3. Holmberg MD, Sievanen H, Tuimala R. Changes in bone mineral density during pregnancy and postpartum: prospective data on five women. Osteoporos Int 1999; 10(1): 41-46. Dostupné z DOI: <http://doi10.1007/s001980050192>. Go to original source...
    4. Kovacs CS, Kronenberg HM. Pregnancy and lactation. In: Bilezikian JP. Primer on the metabolic bone diseases and disorders of mineral metabolism. 9th ed. Wiley Blackwell (USA) 2019 : 147-153. ISBN 9781119266563. Go to original source...
    5. Bayer M. Osteoporóza v graviditě a při laktaci. In: Džupa V, Jenšovský J. Diagnostika a léčba osteoporózy a dalších onemocnění skeletu. Karolinum: Praha 2018 : 135-139. ISBN 978802463761-9.
    6. Pentyala S, Rahman A, Mysore P et al. Osteoporosis associated with pregnancy. iMedPubJournals. 2015; 7, 3 : 6. Dostupné z WWW: <https://www.archivesofmedicine.com/medicine/osteoporosis-associated-with-pregnancy>.
    7. Kovacs CS. Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 2016; 96(2): 449-547. Dostupné z DOI: <http://doi10.1152/physrev.00027.2015>. Go to original source...
    8. Salari P, Abdollahi M. The influence of pregnancy and lactation on maternal bone health: a systematic review. J Family Reprod Health 2014; 8(4): 135-148.
    9. Mamillapalli R, VanHouten J, Dann P et al. Mammary-specific ablation of the calcium-sensing receptor during lactation alters maternal calcium metabolism, milk calcium transport, and neonatal calcium accural. Endocrinology 2013; 154(9): 3031-3042.. Dostupné z DOI: <http://doi10.1210/en.2012-2195>. Go to original source...
    10. Tsvetov G, Levy S, Benbassat C et al. Influence of number of deliveries and total breast-feeding time on bone mineral density in premenopausal and young postmenopausal women. Maturitas 2014; 77(3): 249-254. Dostupné z DOI: <http://doi10.1016/j.maturitas.2013.11.003>. Go to original source...
    11. Khoo CC, Woo J, Leung PC et al. Determinants of bone mineral density in older postmenopausal women. Climacteric 2011; 14(3): 378-383. Dostupné z DOI: <http://doi10.3109/13697137.2010.548566>. Go to original source...
    12. More C, Bettembuk P, Bhattoa HP et al. The effects of pregnancy and lactation on bone mineral density. Osteoporos Int 2001; 12(9): 732-737. Dostupné z DOI: <http://doi10.1007/s001980170048>. Go to original source...
    13. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N Engl J Med 1995; 332(12): 767-773. Dostupné z DOI: <http://doi10.1056/NEJM199503233321202>. Go to original source...
    14. Michaelsson K, Baron JA, Farahmand BY et al. Influence of parity and lactation on hip fracture risk. Am J Epidemiol 2001; 153(12): 1166-1172. Dostupné z DOI: <http://doi10.1093/aje/153.12.1166>. Go to original source...
    15. Cohen A. Premenopausal osteoporosis. Endocrinol Metab Clin North Am 2017; 46(1): 117-133. Dostupné z DOI: <http://doi10.1016/j.ecl.2016.09.007>. Go to original source...
    16. Pikner R. Laboratorní vyšetření v klinické osteologii. In: Džupa V, Jenšovský J (eds) et al. Diagnostika a léčba osteoporózy a dalších onemocnění skeletu. Karolinum: Praha 2018 : 48-62. ISBN 978802463761-9.
    17. Payer J. Prevencia a liečba osteoporózy. In: Killinger Z. Osteoporóza. Herba: Bratislava 2012 : 185-225. ISBN 9788089171941.
    18. Choe EY, Song JE, Park KH et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 2012; 30(5): 596-601. Dostupné z DOI: <http://doi10.1007/s00774-011-0334-0>. Go to original source...
    19. Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP et al. Case report: Teriparatide treatment in a case of severe pregnancy and lactation-associated osteoporosis. Hormones (Athens) 2012; 11(4): 495-500. Dostupné z DOI: <http://doi10.14310/horm.2002.1383>. Go to original source...
    20. Ijuin A, Yoshikata H, Asano R et al. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol 2017; 56(6): 863-866. Dostupné z DOI: <http://doi10.1016/j.tjog.2017.10.028>. Go to original source...
    21. Sokal A, Elefant E, Leturcq T et al. Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study. Osteoporos Int 2019; 30(1): 221-229. Dostupné z DOI: <http://doi10.1007/s00198-018-4672-9>. Go to original source...
    22. Stathopoulos IP, Liakou CG, Katsalira A et al. The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones (Athens) 2011; 10(4): 280-291. Dostupné z DOI: <http://doi10.14310/horm.2002.1319>. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.